 |
National HIV/AIDS Program |  | | |
| Emtriva
(emtricitabine, FTC)
- Type of Drug: Nucleoside Reverse Transcriptase Inhibitor
Nucleoside reverse transcriptase inhibitors were the first type of drug available to treat HIV. They are also known as NRTIs, nucleoside analogues, or "nukes."
When the HIV virus enters a healthy cell, it attempts to make copies of itself. It does this by using an enzyme called reverse transcriptase. NRTIs block that enzyme, so HIV cannot make new copies of itself.
Notes on taking this medication- No food restrictions, can take with or without food
- Persons with kidney problems may need an adjustment to their dose of Emtriva
- Do not take Emtriva with Epivir
Side effects- Skin discoloration (particularly in dark-skinned people)
- Headache; diarrhea; nausea
- Emtriva is active against hepatitis B, and stopping it can cause "flare-up" of hepatitis B
See accompanying chart: Tips for Common Side Effects My doctor's instructionsDisclaimer:This information is not meant to substitute for advice from your medical provider or pharmacist. If you have any questions about your medication dosing, talk to your medical provider or pharmacist. Image of Emtriva is courtesy of T. Van Nunnery | | | |
|
| | |
|
| Reviewed/Updated Date: September 28, 2008 |
|
